Andrea Baldini։ Aspirin Prophylaxis Is Effective But Still Off-Label In Some Countries
Andrea Baldini, Instute Director at IFCA Clinic, shared The Bone and Joint Journal’s post on LinkedIn, adding:
”More and more high level evidence for an established prophylaxis which in my country is still considered ‘off label’…”
The Bone and Joint Journal, shared a post on LinkedIn about a recent article by Billy I. Kim, adding:
”The risk of thromboembolic events must be weighed against the increased potential for bleeding with more potent anticoagulants.”
Title: Aspirin prophylaxis is safe and effective for venous thromboembolism prophylaxis in low-risk patients undergoing aseptic revision total knee arthroplasty
Authors: Billy I. Kim, Brian P. Chalmers, Fred D. Cushner, Peter K. Sculco
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care